AP3B1 and pulmonary fibrosis: Interestingly, HPS2 iPSC‐derived AECs recapitulated the disease phenotype, with altered surfactant secretion, and can therefore be instrumental for future studies aiming to discover new therapeutic agents for the treatment of HPS pulmonary fibrosis.